A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
PHASE3CompletedINTERVENTIONAL
Enrollment
523
Participants
Timeline
Start Date
Not specified
Study Completion Date
July 31, 1991
Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Janssen, LP
INDUSTRY
NCT00249132 - A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia | Biotech Hunter | Biotech Hunter